The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs.
COVID-19
Discrimination
Disinformation
People who inject drugs
Psychometrics
Resilience
Journal
Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
received:
05
05
2022
revised:
27
02
2023
accepted:
28
02
2023
medline:
25
4
2023
pubmed:
17
3
2023
entrez:
16
3
2023
Statut:
ppublish
Résumé
Due to the persistence of COVID-19, it remains important to measure and examine potential barriers to COVID-19 prevention and treatment to avert additional loss of life, particularly among stigmatized populations, such as people who inject drugs (PWID), who are at high risk for contracting and spreading SARS-CoV-2. We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to adversity, and endorsement of COVID-19 disinformation. We assessed internal reliability, structural validity and construct validity of a 4-item COVID-19 response-related discrimination scale among PWID living in San Diego County, completing interviewer-administered surveys between October 2020 and September 2021. Using negative binomial regression, we assessed the relationship between COVID-19 response-related discrimination and disinformation and the potential moderating role of resilience. Of 381 PWID, mean age was 42.6 years and the majority were male (75.6 %) and Hispanic (61.9 %). The COVID-19 response-related discrimination scale had modest reliability (α = 0.66, ω = 0.66) as a single construct with acceptable construct validity (all p ≤ 0.05). Among 216 PWID who completed supplemental surveys, a significant association between COVID-19 response-related discrimination and COVID-19 disinformation was observed, which was moderated by resilience (p = 0.044). Specifically, among PWID with high levels of resilience, endorsement of COVID-19 disinformation significantly increased as exposure to COVID-19 response-related discrimination increased (p = 0.011). These findings suggest that intervening on COVID-19 response-related discrimination may offset the negative outcomes associated with COVID-19 disinformation.
Sections du résumé
BACKGROUND
Due to the persistence of COVID-19, it remains important to measure and examine potential barriers to COVID-19 prevention and treatment to avert additional loss of life, particularly among stigmatized populations, such as people who inject drugs (PWID), who are at high risk for contracting and spreading SARS-CoV-2. We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to adversity, and endorsement of COVID-19 disinformation.
METHODS
We assessed internal reliability, structural validity and construct validity of a 4-item COVID-19 response-related discrimination scale among PWID living in San Diego County, completing interviewer-administered surveys between October 2020 and September 2021. Using negative binomial regression, we assessed the relationship between COVID-19 response-related discrimination and disinformation and the potential moderating role of resilience.
RESULTS
Of 381 PWID, mean age was 42.6 years and the majority were male (75.6 %) and Hispanic (61.9 %). The COVID-19 response-related discrimination scale had modest reliability (α = 0.66, ω = 0.66) as a single construct with acceptable construct validity (all p ≤ 0.05). Among 216 PWID who completed supplemental surveys, a significant association between COVID-19 response-related discrimination and COVID-19 disinformation was observed, which was moderated by resilience (p = 0.044). Specifically, among PWID with high levels of resilience, endorsement of COVID-19 disinformation significantly increased as exposure to COVID-19 response-related discrimination increased (p = 0.011).
CONCLUSIONS
These findings suggest that intervening on COVID-19 response-related discrimination may offset the negative outcomes associated with COVID-19 disinformation.
Identifiants
pubmed: 36924661
pii: S0376-8716(23)00069-8
doi: 10.1016/j.drugalcdep.2023.109831
pmc: PMC9981478
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
109831Subventions
Organisme : NIDA NIH HHS
ID : K01 DA055521
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA049644
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123282
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflict of interest.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychol Bull. 1995 Nov;118(3):392-404
pubmed: 7501743
Soc Sci Med. 2008 Aug;67(3):358-67
pubmed: 18524444
AIDS Behav. 2020 Oct;24(10):2776-2780
pubmed: 32440972
Lancet. 2006 Feb 11;367(9509):528-9
pubmed: 16473129
J Behav Med. 2013 Jun;36(3):270-82
pubmed: 22526525
Int J Health Serv. 2014;44(4):643-710
pubmed: 25626224
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
J Racial Ethn Health Disparities. 2022 Aug;9(4):1430-1442
pubmed: 34117633
Front Psychol. 2020 Oct 23;11:566790
pubmed: 33192844
Bull World Health Organ. 2007 Nov;85(11):867-72
pubmed: 18038077
Int J Equity Health. 2021 Jan 6;20(1):14
pubmed: 33407521
J Int AIDS Soc. 2020 Jul;23(7):e25583
pubmed: 32697423
PLoS Med. 2019 Nov 26;16(11):e1002969
pubmed: 31770387
Psychol Assess. 2016 Jan;28(1):51-8
pubmed: 26146948
JAMA Psychiatry. 2022 Sep 1;79(9):898-906
pubmed: 35895053
Am J Public Health. 2021 Jul;111(S2):S73-S74
pubmed: 34314215
PLoS One. 2021 Nov 22;16(11):e0260286
pubmed: 34807963
J Anxiety Disord. 2020 Oct;75:102289
pubmed: 32853884
Health Aff (Millwood). 2022 Feb;41(2):171-178
pubmed: 35130057
Lancet Infect Dis. 2020 Jul;20(7):782
pubmed: 32592670
J Clin Psychiatry. 2006 Feb;67(2):247-57
pubmed: 16566620
Clin Infect Dis. 2022 Aug 24;75(1):e726-e733
pubmed: 35024825
Int J Behav Med. 2008;15(3):194-200
pubmed: 18696313
Soc Sci Med. 2020 Oct;263:113356
pubmed: 32967786
Am J Public Health. 2022 Mar;112(3):401-404
pubmed: 35196050
BMJ Open. 2021 Nov 2;11(11):e048241
pubmed: 34728443
Harm Reduct J. 2020 May 6;17(1):26
pubmed: 32375887
Epidemiol Psychiatr Sci. 2022 May 26;31:e37
pubmed: 35616053
Br J Psychol. 2014 Aug;105(3):399-412
pubmed: 24844115
J Int AIDS Soc. 2020 May;23(5):e25504
pubmed: 32365283
J Multidiscip Healthc. 2021 Nov 10;14:3125-3134
pubmed: 34795485